-
DE
D64.4 is the ICD-10 code for congenital sideroblastic anemia, a rare inherited blood disorder in which iron cannot be properly incorporated into red blood cells.
Regular tips about health Regular tips about health Add as Preferred SourceD64.4 is the ICD-10 code for congenital sideroblastic anemia, a rare inherited blood disorder in which iron cannot be properly incorporated into red blood cells.
The ICD-10 code D64.4 refers to congenital sideroblastic anemia (also known as hereditary sideroblastic anemia). This is a rare, inherited form of anemia in which the body absorbs sufficient iron but is unable to incorporate it correctly into hemoglobin, the oxygen-carrying protein in red blood cells. As a result, iron accumulates in the precursors of red blood cells (erythroblasts) and forms ring-shaped deposits around the cell nucleus – these are known as ring sideroblasts, which give the condition its name.
Congenital sideroblastic anemia is caused by genetic mutations that impair iron metabolism or the synthesis of heme (the iron-containing component of hemoglobin). The most common form is X-linked and primarily affects male patients. It is usually caused by a mutation in the ALAS2 gene, which encodes the enzyme delta-aminolevulinic acid synthase 2 – a key enzyme in heme biosynthesis. Rarer forms follow autosomal-recessive or autosomal-dominant inheritance patterns.
The severity of symptoms can vary widely depending on the genetic cause and individual disease course. Common symptoms include:
Diagnosing congenital sideroblastic anemia involves several steps:
Treatment depends on the severity of the anemia and the underlying genetic cause:
In the most common form (ALAS2 mutation), some patients respond well to high-dose pyridoxine (vitamin B6), as it can support the activity of the defective enzyme. This may lead to a significant improvement in anemia.
In cases of severe anemia that do not respond to pyridoxine, regular blood transfusions are required to maintain adequate hemoglobin levels.
Because the condition – particularly when combined with repeated transfusions – can lead to iron overload in the organs, chelation therapy is often used (e.g., with deferoxamine or deferasirox) to remove excess iron from the body.
In severe cases, especially in children with non-pyridoxine-responsive forms, an allogeneic stem cell transplantation may offer a curative option.
The prognosis strongly depends on the genetic form and the response to therapy. Patients who respond to pyridoxine can achieve a near-normal life expectancy. In severe, transfusion-dependent forms, long-term iron overload poses the greatest risk to organ health.
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Average rating of 4.97 out of 5 stars
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
Average rating of 4.85 out of 5 stars
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
Average rating of 4.86 out of 5 stars
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
Average rating of 4.94 out of 5 stars
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.